Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 189

1.

Invasive fungal infections in children with acute lymphoblastic leukaemia: Results from four Australian centres, 2003-2013.

Wang SS, Kotecha RS, Bernard A, Blyth CC, McMullan BJ, Cann MP, Yeoh DK, Bartlett AW, Ryan AL, Moore AS, Bryant PA, Clark J, Haeusler GM.

Pediatr Blood Cancer. 2019 Oct;66(10):e27915. doi: 10.1002/pbc.27915. Epub 2019 Jul 16.

PMID:
31309711
2.

Hematopoietic stem cell transplantation for children with acute myeloid leukemia in second remission: A report from the Australasian Bone Marrow Transplant Recipient Registry and the Australian and New Zealand Children's Haematology Oncology Group.

Selim A, Alvaro F, Cole CH, Fraser CJ, Mechinaud F, O'Brien TA, Shaw PJ, Tapp H, Teague L, Nivison-Smith I, Moore AS.

Pediatr Blood Cancer. 2019 Aug;66(8):e27812. doi: 10.1002/pbc.27812. Epub 2019 May 20.

PMID:
31111633
3.

ALK2 inhibitors display beneficial effects in preclinical models of ACVR1 mutant diffuse intrinsic pontine glioma.

Carvalho D, Taylor KR, Olaciregui NG, Molinari V, Clarke M, Mackay A, Ruddle R, Henley A, Valenti M, Hayes A, Brandon AH, Eccles SA, Raynaud F, Boudhar A, Monje M, Popov S, Moore AS, Mora J, Cruz O, Vinci M, Brennan PE, Bullock AN, Carcaboso AM, Jones C.

Commun Biol. 2019 May 9;2:156. doi: 10.1038/s42003-019-0420-8. eCollection 2019.

4.

Stage at diagnosis for children with blood cancers in Australia: Application of the Toronto Paediatric Cancer Stage Guidelines in a population-based national childhood cancer registry.

Youlden DR, Gupta S, Frazier AL, Moore AS, Baade PD, Valery PC, Green AC, Aitken JF.

Pediatr Blood Cancer. 2019 Jun;66(6):e27683. doi: 10.1002/pbc.27683. Epub 2019 Feb 25.

PMID:
30803139
5.

Imaging the Dynamics of Mitophagy in Live Cells.

Moore AS, Holzbaur ELF.

Methods Mol Biol. 2019;1880:601-610. doi: 10.1007/978-1-4939-8873-0_39.

PMID:
30610725
6.

Retrospective study of survival time and prognostic factors for dogs with small intestinal adenocarcinoma treated by tumor excision with or without adjuvant chemotherapy.

Smith AA, Frimberger AE, Moore AS.

J Am Vet Med Assoc. 2019 Jan 15;254(2):243-250. doi: 10.2460/javma.254.2.243.

PMID:
30605388
7.

Mitochondrial-cytoskeletal interactions: dynamic associations that facilitate network function and remodeling.

Moore AS, Holzbaur ELF.

Curr Opin Physiol. 2018 Jun;3:94-100. doi: 10.1016/j.cophys.2018.03.003. Epub 2018 Apr 7.

8.

Dosage escalation of intravenous cyclophosphamide in cats with cancer.

Moore AS, Frimberger AE, Chan CM.

Vet J. 2018 Dec;242:39-43. doi: 10.1016/j.tvjl.2018.10.003. Epub 2018 Oct 16.

PMID:
30503542
9.

Epidemiology of invasive fungal infections in immunocompromised children; an Australian national 10-year review.

Bartlett AW, Cann MP, Yeoh DK, Bernard A, Ryan AL, Blyth CC, Kotecha RS, McMullan BJ, Moore AS, Haeusler GM, Clark JE.

Pediatr Blood Cancer. 2019 Apr;66(4):e27564. doi: 10.1002/pbc.27564. Epub 2018 Dec 4.

PMID:
30511385
10.

Uncertainty analysis of response functions and γ -backgrounds on Tion and t0 measurements from Cherenkov neutron detectors at the National Ignition Facility (NIF).

Hartouni EP, Beeman B, Eckart MJ, Grim GP, Hatarik R, Moore AS, Rubery M, Sayre D, Schlossberg DJ, Waltz C.

Rev Sci Instrum. 2018 Oct;89(10):10I140. doi: 10.1063/1.5038816.

PMID:
30399962
11.

Characterization of photodetector temporal response for neutron time-of-flight (nToF) diagnostics at the National Ignition Facility.

Gordon JM, Schlossberg DJ, Eckart MJ, Datte PS, Durand CE, Grim GP, Hartouni EP, Hatarik R, Moore AS.

Rev Sci Instrum. 2018 Oct;89(10):10I135. doi: 10.1063/1.5039390.

PMID:
30399914
12.

Testing a Cherenkov neutron time-of-flight detector on OMEGA.

Glebov VY, Eckart MJ, Forrest CJ, Grim GP, Hartouni EP, Hatarik R, Knauer JP, Moore AS, Regan SP, Sangster TC, Schlossberg DJ, Stoeckl C.

Rev Sci Instrum. 2018 Oct;89(10):10I122. doi: 10.1063/1.5035289.

PMID:
30399883
13.

Simultaneous visualization of wall motion, beam propagation, and implosion symmetry on the National Ignition Facility (invited).

Izumi N, Meezan NB, Johnson S, Woodworth BN, Woods T, Jones OS, Landen OL, Kroll JJ, Vonhof S, Nikroo A, Jaquez J, Kangas K, Bailey C, Hardy M, Ehrlich R, Ralph J, Town RP, Bradley DK, Hinkel DE, Moore AS, Divol L, Young C, Moody JD.

Rev Sci Instrum. 2018 Oct;89(10):10K111. doi: 10.1063/1.5039364.

PMID:
30399855
14.

A fused silica Cherenkov radiator for high precision time-of-flight measurement of DT γ and neutron spectra (invited).

Moore AS, Schlossberg DJ, Hartouni EP, Sayre D, Eckart MJ, Hatarik R, Barbosa F, Root J, Waltz C, Beeman B, Rubery MS, Grim GP.

Rev Sci Instrum. 2018 Oct;89(10):10I120. doi: 10.1063/1.5039322.

PMID:
30399816
15.

Ab initio response functions for Cherenkov-based neutron detectors.

Schlossberg DJ, Moore AS, Beeman BV, Eckart MJ, Grim GP, Hartouni EP, Hatarik R, Rubery MS, Sayre DB, Waltz C.

Rev Sci Instrum. 2018 Oct;89(10):10I136. doi: 10.1063/1.5039399.

PMID:
30399741
16.

Using multiple neutron time of flight detectors to determine the hot spot velocity.

Hatarik R, Nora RC, Spears BK, Eckart MJ, Grim GP, Hartouni EP, Moore AS, Schlossberg DJ.

Rev Sci Instrum. 2018 Oct;89(10):10I138. doi: 10.1063/1.5039372.

PMID:
30399709
17.

The genetic basis and cell of origin of mixed phenotype acute leukaemia.

Alexander TB, Gu Z, Iacobucci I, Dickerson K, Choi JK, Xu B, Payne-Turner D, Yoshihara H, Loh ML, Horan J, Buldini B, Basso G, Elitzur S, de Haas V, Zwaan CM, Yeoh A, Reinhardt D, Tomizawa D, Kiyokawa N, Lammens T, De Moerloose B, Catchpoole D, Hori H, Moorman A, Moore AS, Hrusak O, Meshinchi S, Orgel E, Devidas M, Borowitz M, Wood B, Heerema NA, Carrol A, Yang YL, Smith MA, Davidsen TM, Hermida LC, Gesuwan P, Marra MA, Ma Y, Mungall AJ, Moore RA, Jones SJM, Valentine M, Janke LJ, Rubnitz JE, Pui CH, Ding L, Liu Y, Zhang J, Nichols KE, Downing JR, Cao X, Shi L, Pounds S, Newman S, Pei D, Guidry Auvil JM, Gerhard DS, Hunger SP, Inaba H, Mullighan CG.

Nature. 2018 Oct;562(7727):373-379. doi: 10.1038/s41586-018-0436-0. Epub 2018 Sep 12.

18.

Therapy-related acute myeloid leukemia following treatment for cancer in childhood: A population-based registry study.

Brown CA, Youlden DR, Aitken JF, Moore AS.

Pediatr Blood Cancer. 2018 Dec;65(12):e27410. doi: 10.1002/pbc.27410. Epub 2018 Sep 5.

PMID:
30183136
19.

Assessing the feasibility and validity of the Toronto Childhood Cancer Stage Guidelines: a population-based registry study.

Aitken JF, Youlden DR, Moore AS, Baade PD, Ward LJ, Thursfield VJ, Valery PC, Green AC, Gupta S, Frazier AL.

Lancet Child Adolesc Health. 2018 Mar;2(3):173-179. doi: 10.1016/S2352-4642(18)30023-3. Epub 2018 Feb 1.

PMID:
30169253
20.

Functional diversity and cooperativity between subclonal populations of pediatric glioblastoma and diffuse intrinsic pontine glioma cells.

Vinci M, Burford A, Molinari V, Kessler K, Popov S, Clarke M, Taylor KR, Pemberton HN, Lord CJ, Gutteridge A, Forshew T, Carvalho D, Marshall LV, Qin EY, Ingram WJ, Moore AS, Ng HK, Trabelsi S, H'mida-Ben Brahim D, Entz-Werle N, Zacharoulis S, Vaidya S, Mandeville HC, Bridges LR, Martin AJ, Al-Sarraj S, Chandler C, Sunol M, Mora J, de Torres C, Cruz O, Carcaboso AM, Monje M, Mackay A, Jones C.

Nat Med. 2018 Aug;24(8):1204-1215. doi: 10.1038/s41591-018-0086-7. Epub 2018 Jul 2.

21.

Molecular Minimal Residual Disease Monitoring in Acute Myeloid Leukemia: Challenges and Future Directions.

Selim AG, Moore AS.

J Mol Diagn. 2018 Jul;20(4):389-397. doi: 10.1016/j.jmoldx.2018.03.005. Epub 2018 Apr 22. Review.

PMID:
29689379
22.

Usefulness of chemotherapy for the treatment of very elderly dogs with multicentric lymphoma.

Moore AS, Frimberger AE.

J Am Vet Med Assoc. 2018 Apr 1;252(7):852-859. doi: 10.2460/javma.252.7.852.

PMID:
29553895
23.

The ten-year evolutionary trajectory of a highly recurrent paediatric high grade neuroepithelial tumour with MN1:BEND2 fusion.

Burford A, Mackay A, Popov S, Vinci M, Carvalho D, Clarke M, Izquierdo E, Avery A, Jacques TS, Ingram WJ, Moore AS, Frawley K, Hassall TE, Robertson T, Jones C.

Sci Rep. 2018 Jan 18;8(1):1032. doi: 10.1038/s41598-018-19389-9.

24.

Development of a targeted sequencing approach to identify prognostic, predictive and diagnostic markers in paediatric solid tumours.

Izquierdo E, Yuan L, George S, Hubank M, Jones C, Proszek P, Shipley J, Gatz SA, Stinson C, Moore AS, Clifford SC, Hicks D, Lindsey JC, Hill RM, Jacques TS, Chalker J, Thway K, O'Connor S, Marshall L, Moreno L, Pearson A, Chesler L, Walker BA, De Castro DG.

Oncotarget. 2017 Dec 6;8(67):112036-112050. doi: 10.18632/oncotarget.23000. eCollection 2017 Dec 19.

25.

Targeted Next-Generation Sequencing for Detecting MLL Gene Fusions in Leukemia.

Afrin S, Zhang CRC, Meyer C, Stinson CL, Pham T, Bruxner TJC, Venn NC, Trahair TN, Sutton R, Marschalek R, Fink JL, Moore AS.

Mol Cancer Res. 2018 Feb;16(2):279-285. doi: 10.1158/1541-7786.MCR-17-0569. Epub 2017 Nov 13.

26.

Capsule implosions for continuum x-ray backlighting of opacity samples at the National Ignition Facility.

Opachich YP, Heeter RF, Barrios MA, Garcia EM, Craxton RS, King JA, Liedahl DA, McKenty PW, Schneider MB, May MJ, Zhang R, Ross PW, Kline JL, Moore AS, Weaver JL, Flippo KA, Perry TS.

Phys Plasmas. 2017 Jun;24(6):063301. doi: 10.1063/1.4985076. Epub 2017 Jun 8.

27.

Absolute calibration of optical streak cameras on picosecond time scales using supercontinuum generation.

Patankar S, Gumbrell ET, Robinson TS, Floyd E, Stuart NH, Moore AS, Skidmore JW, Smith RA.

Appl Opt. 2017 Aug 20;56(24):6982-6987. doi: 10.1364/AO.56.006982.

28.

Clinical outcome and prognosis of dogs with histopathological features consistent with epitheliotropic lymphoma: a retrospective study of 148 cases (2003-2015).

Chan CM, Frimberger AE, Moore AS.

Vet Dermatol. 2018 Apr;29(2):154-e59. doi: 10.1111/vde.12504. Epub 2017 Oct 6. Review.

PMID:
28983988
29.

Integrated Molecular Meta-Analysis of 1,000 Pediatric High-Grade and Diffuse Intrinsic Pontine Glioma.

Mackay A, Burford A, Carvalho D, Izquierdo E, Fazal-Salom J, Taylor KR, Bjerke L, Clarke M, Vinci M, Nandhabalan M, Temelso S, Popov S, Molinari V, Raman P, Waanders AJ, Han HJ, Gupta S, Marshall L, Zacharoulis S, Vaidya S, Mandeville HC, Bridges LR, Martin AJ, Al-Sarraj S, Chandler C, Ng HK, Li X, Mu K, Trabelsi S, Brahim DH, Kisljakov AN, Konovalov DM, Moore AS, Carcaboso AM, Sunol M, de Torres C, Cruz O, Mora J, Shats LI, Stavale JN, Bidinotto LT, Reis RM, Entz-Werle N, Farrell M, Cryan J, Crimmins D, Caird J, Pears J, Monje M, Debily MA, Castel D, Grill J, Hawkins C, Nikbakht H, Jabado N, Baker SJ, Pfister SM, Jones DTW, Fouladi M, von Bueren AO, Baudis M, Resnick A, Jones C.

Cancer Cell. 2017 Oct 9;32(4):520-537.e5. doi: 10.1016/j.ccell.2017.08.017. Epub 2017 Sep 28.

30.

High prevalence of relapse in children with Philadelphia-like acute lymphoblastic leukemia despite risk-adapted treatment.

Heatley SL, Sadras T, Kok CH, Nievergall E, Quek K, Dang P, McClure B, Venn N, Moore S, Suttle J, Law T, Ng A, Muskovic W, Norris MD, Revesz T, Osborn M, Moore AS, Suppiah R, Fraser C, Alvaro F, Hughes TP, Mullighan CG, Marshall GM, Pozza LD, Yeung DT, Sutton R, White DL.

Haematologica. 2017 Dec;102(12):e490-e493. doi: 10.3324/haematol.2016.162925. Epub 2017 Sep 21. No abstract available.

31.

Differential expression of MUC4, GPR110 and IL2RA defines two groups of CRLF2-rearranged acute lymphoblastic leukemia patients with distinct secondary lesions.

Sadras T, Heatley SL, Kok CH, Dang P, Galbraith KM, McClure BJ, Muskovic W, Venn NC, Moore S, Osborn M, Revesz T, Moore AS, Hughes TP, Yeung D, Sutton R, White DL.

Cancer Lett. 2017 Nov 1;408:92-101. doi: 10.1016/j.canlet.2017.08.034. Epub 2017 Sep 1.

PMID:
28866095
32.
33.

The MLL recombinome of acute leukemias in 2017.

Meyer C, Burmeister T, Gröger D, Tsaur G, Fechina L, Renneville A, Sutton R, Venn NC, Emerenciano M, Pombo-de-Oliveira MS, Barbieri Blunck C, Almeida Lopes B, Zuna J, Trka J, Ballerini P, Lapillonne H, De Braekeleer M, Cazzaniga G, Corral Abascal L, van der Velden VHJ, Delabesse E, Park TS, Oh SH, Silva MLM, Lund-Aho T, Juvonen V, Moore AS, Heidenreich O, Vormoor J, Zerkalenkova E, Olshanskaya Y, Bueno C, Menendez P, Teigler-Schlegel A, Zur Stadt U, Lentes J, Göhring G, Kustanovich A, Aleinikova O, Schäfer BW, Kubetzko S, Madsen HO, Gruhn B, Duarte X, Gameiro P, Lippert E, Bidet A, Cayuela JM, Clappier E, Alonso CN, Zwaan CM, van den Heuvel-Eibrink MM, Izraeli S, Trakhtenbrot L, Archer P, Hancock J, Möricke A, Alten J, Schrappe M, Stanulla M, Strehl S, Attarbaschi A, Dworzak M, Haas OA, Panzer-Grümayer R, Sedék L, Szczepański T, Caye A, Suarez L, Cavé H, Marschalek R.

Leukemia. 2018 Feb;32(2):273-284. doi: 10.1038/leu.2017.213. Epub 2017 Jul 13.

34.

Long-term control of olfactory neuroblastoma in a dog treated with surgery and radiation therapy.

Gumpel E, Moore AS, Simpson DJ, Hoffmann KL, Taylor DP.

Aust Vet J. 2017 Jul;95(7):227-231. doi: 10.1111/avj.12602.

PMID:
28653386
35.

Progress towards a more predictive model for hohlraum radiation drive and symmetry.

Jones OS, Suter LJ, Scott HA, Barrios MA, Farmer WA, Hansen SB, Liedahl DA, Mauche CW, Moore AS, Rosen MD, Salmonson JD, Strozzi DJ, Thomas CA, Turnbull DP.

Phys Plasmas. 2017 May;24(5):056312. doi: 10.1063/1.4982693. Epub 2017 May 19.

36.

Intertumoral Heterogeneity within Medulloblastoma Subgroups.

Cavalli FMG, Remke M, Rampasek L, Peacock J, Shih DJH, Luu B, Garzia L, Torchia J, Nor C, Morrissy AS, Agnihotri S, Thompson YY, Kuzan-Fischer CM, Farooq H, Isaev K, Daniels C, Cho BK, Kim SK, Wang KC, Lee JY, Grajkowska WA, Perek-Polnik M, Vasiljevic A, Faure-Conter C, Jouvet A, Giannini C, Nageswara Rao AA, Li KKW, Ng HK, Eberhart CG, Pollack IF, Hamilton RL, Gillespie GY, Olson JM, Leary S, Weiss WA, Lach B, Chambless LB, Thompson RC, Cooper MK, Vibhakar R, Hauser P, van Veelen MC, Kros JM, French PJ, Ra YS, Kumabe T, López-Aguilar E, Zitterbart K, Sterba J, Finocchiaro G, Massimino M, Van Meir EG, Osuka S, Shofuda T, Klekner A, Zollo M, Leonard JR, Rubin JB, Jabado N, Albrecht S, Mora J, Van Meter TE, Jung S, Moore AS, Hallahan AR, Chan JA, Tirapelli DPC, Carlotti CG, Fouladi M, Pimentel J, Faria CC, Saad AG, Massimi L, Liau LM, Wheeler H, Nakamura H, Elbabaa SK, Perezpeña-Diazconti M, Chico Ponce de León F, Robinson S, Zapotocky M, Lassaletta A, Huang A, Hawkins CE, Tabori U, Bouffet E, Bartels U, Dirks PB, Rutka JT, Bader GD, Reimand J, Goldenberg A, Ramaswamy V, Taylor MD.

Cancer Cell. 2017 Jun 12;31(6):737-754.e6. doi: 10.1016/j.ccell.2017.05.005.

37.

Erratum to: Population pharmacokinetic modelling of doxorubicin and doxorubicinol in children with cancer: is there a relationship with cardiac troponin profiles?

Kunarajah K, Hennig S, Norris RLG, Lobb M, Charles BG, Pinkerton R, Moore AS.

Cancer Chemother Pharmacol. 2017 Jul;80(1):27-28. doi: 10.1007/s00280-017-3338-1. No abstract available.

PMID:
28597037
38.

Introduction: Searching for the Historical Roots of 11 March 2011.

Onaga L, Moore AS.

Technol Cult. 2017;58(1):154-158. doi: 10.1353/tech.2017.0005.

PMID:
28569708
39.

Canine Cutaneous Plasmacytosis: 21 Cases (2005-2015).

Boostrom BO, Moore AS, DeRegis CJ, Robat C, Freeman K, Thamm DH.

J Vet Intern Med. 2017 Jul;31(4):1074-1080. doi: 10.1111/jvim.14729. Epub 2017 May 17.

40.

Population pharmacokinetic modelling of doxorubicin and doxorubicinol in children with cancer: is there a relationship with cardiac troponin profiles?

Kunarajah K, Hennig S, Norris RLG, Lobb M, Charles BG, Pinkerton R, Moore AS.

Cancer Chemother Pharmacol. 2017 Jul;80(1):15-25. doi: 10.1007/s00280-017-3309-6. Epub 2017 Apr 25. Erratum in: Cancer Chemother Pharmacol. 2017 Jul;80(1):27-28.

PMID:
28444427
41.

Chemotherapy for dogs with lymph node metastasis from histiocytic sarcomas.

Moore AS, Taylor DP, Reppas G, Frimberger AE.

Aust Vet J. 2017 Jan;95(1-2):37-40. doi: 10.1111/avj.12522.

PMID:
28124419
42.

Integrated (epi)-Genomic Analyses Identify Subgroup-Specific Therapeutic Targets in CNS Rhabdoid Tumors.

Torchia J, Golbourn B, Feng S, Ho KC, Sin-Chan P, Vasiljevic A, Norman JD, Guilhamon P, Garzia L, Agamez NR, Lu M, Chan TS, Picard D, de Antonellis P, Khuong-Quang DA, Planello AC, Zeller C, Barsyte-Lovejoy D, Lafay-Cousin L, Letourneau L, Bourgey M, Yu M, Gendoo DMA, Dzamba M, Barszczyk M, Medina T, Riemenschneider AN, Morrissy AS, Ra YS, Ramaswamy V, Remke M, Dunham CP, Yip S, Ng HK, Lu JQ, Mehta V, Albrecht S, Pimentel J, Chan JA, Somers GR, Faria CC, Roque L, Fouladi M, Hoffman LM, Moore AS, Wang Y, Choi SA, Hansford JR, Catchpoole D, Birks DK, Foreman NK, Strother D, Klekner A, Bognár L, Garami M, Hauser P, Hortobágyi T, Wilson B, Hukin J, Carret AS, Van Meter TE, Hwang EI, Gajjar A, Chiou SH, Nakamura H, Toledano H, Fried I, Fults D, Wataya T, Fryer C, Eisenstat DD, Scheinemann K, Fleming AJ, Johnston DL, Michaud J, Zelcer S, Hammond R, Afzal S, Ramsay DA, Sirachainan N, Hongeng S, Larbcharoensub N, Grundy RG, Lulla RR, Fangusaro JR, Druker H, Bartels U, Grant R, Malkin D, McGlade CJ, Nicolaides T, Tihan T, Phillips J, Majewski J, Montpetit A, Bourque G, Bader GD, Reddy AT, Gillespie GY, Warmuth-Metz M, Rutkowski S, Tabori U, Lupien M, Brudno M, Schüller U, Pietsch T, Judkins AR, Hawkins CE, Bouffet E, Kim SK, Dirks PB, Taylor MD, Erdreich-Epstein A, Arrowsmith CH, De Carvalho DD, Rutka JT, Jabado N, Huang A.

Cancer Cell. 2016 Dec 12;30(6):891-908. doi: 10.1016/j.ccell.2016.11.003.

43.

EphA3 as a target for antibody immunotherapy in acute lymphoblastic leukemia.

Charmsaz S, Al-Ejeh F, Yeadon TM, Miller KJ, Smith FM, Stringer BW, Moore AS, Lee FT, Cooper LT, Stylianou C, Yarranton GT, Woronicz J, Scott AM, Lackmann M, Boyd AW.

Leukemia. 2017 Aug;31(8):1779-1787. doi: 10.1038/leu.2016.371. Epub 2016 Dec 6.

PMID:
27922598
44.

Two-color spatial and temporal temperature measurements using a streaked soft x-ray imager.

Moore AS, Benstead J, Ahmed MF, Morton J, Guymer TM, Soufli R, Pardini T, Hibbard RL, Bailey CG, Bell PM, Hau-Riege S, Bedzyk M, Shoup MJ 3rd, Regan SP, Agliata T, Jungquist R, Schmidt DW, Kot LB, Garbett WJ, Rubery MS, Skidmore JW, Gullikson E, Salmassi F.

Rev Sci Instrum. 2016 Nov;87(11):11E313.

PMID:
27910456
45.

Uncertainty analysis of signal deconvolution using a measured instrument response function.

Hartouni EP, Beeman B, Caggiano JA, Cerjan C, Eckart MJ, Grim GP, Hatarik R, Moore AS, Munro DH, Phillips T, Sayre DB.

Rev Sci Instrum. 2016 Nov;87(11):11D841.

PMID:
27910423
46.

Impulse responses of visible phototubes used in National Ignition Facility neutron time of flight diagnostics.

Datte PS, Eckart M, Moore AS, Thompson W, Vergel de Dios G.

Rev Sci Instrum. 2016 Nov;87(11):11D837.

PMID:
27910365
47.

A phase I/II trial of AT9283, a selective inhibitor of aurora kinase in children with relapsed or refractory acute leukemia: challenges to run early phase clinical trials for children with leukemia.

Vormoor B, Veal GJ, Griffin MJ, Boddy AV, Irving J, Minto L, Case M, Banerji U, Swales KE, Tall JR, Moore AS, Toguchi M, Acton G, Dyer K, Schwab C, Harrison CJ, Grainger JD, Lancaster D, Kearns P, Hargrave D, Vormoor J.

Pediatr Blood Cancer. 2017 Jun;64(6). doi: 10.1002/pbc.26351. Epub 2016 Dec 1.

PMID:
27905678
49.

Primary nodal hemangiosarcoma in four dogs.

Chan CM, Zwahlen CH, de Lorimier LP, Yeomans SM, Hoffmann KL, Moore AS.

J Am Vet Med Assoc. 2016 Nov 1;249(9):1053-1060.

PMID:
27767434
50.

A literature review of reports of the stability and storage of common injectable chemotherapy agents used in veterinary patients.

Chan CM, Frimberger AE, Moore AS.

Vet Comp Oncol. 2017 Dec;15(4):1124-1135. doi: 10.1111/vco.12271. Epub 2016 Oct 2. Review.

PMID:
27696684

Supplemental Content

Loading ...
Support Center